Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Geersing

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Annals of Internal Medicine|September 13, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2021
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
BMJ Open|March 23, 2024
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trialJ Louise I Burggraaf-van Delft, Nienke van Rein, Remy H H Bemelmans, et al.
BMJ Open|August 27, 2020
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillationGordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Annals of Internal Medicine|September 13, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2021
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
BMJ Open|March 23, 2024
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trialJ Louise I Burggraaf-van Delft, Nienke van Rein, Remy H H Bemelmans, et al.
BMJ Open|August 27, 2020
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillationGordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, et al.
Pageof 13